Zoledronic Acid
Zoledronic Acid is a premium-grade, third-generation nitrogen-containing bisphosphonate active pharmaceutical ingredient (API) with CAS number 118072-93-8. This high-purity, highly potent bone-resorption inhibitor is widely utilized across the global oncology and endocrinology sectors to manufacture clinical-strength intravenous infusions and advanced osteoporosis treatments.
Description
Comprehensive Product Overview of Zoledronic Acid
Exceptional digestibility and rapid bone tissue affinity provide a major competitive advantage in the formulation of therapeutic treatments. This active pharmaceutical ingredient works by providing the essential structural mechanisms—specifically targeting calcium crystals to disrupt osteoclast-mediated bone breakdown—needed for effective systemic modulation. It helps manufacturers achieve potent therapeutic profiles in oncology and bone density products without sacrificing formula stability. For instance, Zoledronic Acid is frequently used as a primary ingredient in clinical-strength hypercalcemia management setups. Consequently, it improves the final clinical efficacy of acute bone mineral density preservation routines. As a result, Zyntex ensures low heavy metal content and strict microbiological control for our supply, ensuring maximum safety during your manufacturing cycle.
Moreover, Zyntex supplies specialized fine crystalline powder grades for the medical research and fine pharmaceutical compounding industries. This compound acts as a critical structural asset, helping to enhance the systemic skeletal mechanisms of biological matrices undergoing severe mineral loss exposure. It pushes the boundaries of medical science by offering a highly stable active source that does not affect the final solution’s processing parameters during liquid vial autoclaving. At the same time, it serves as a crucial biomaterial matrix in the synthesis of specialized prolonged-release matrices and targeted prescription intermediates. In short, our product serves as a dependable “structural matrix.” It supports both the vitality of the human body and the precision of modern biomedical engineering.
Key Industrial Applications for Zoledronic Acid
This high-purity bioavailable nitrogenous bisphosphonate active is essential in these four primary sectors:
💉 Sterile Infusions
Primary active source for compounding intravenous ready-to-use solutions and concentrated vials. Thus, it provides essential support for systemic skeletal delivery lines.
🏥 Oncological Care
Key drug block utilized for managing bone complications associated with advanced tumor therapies. Undoubtedly, it is vital for enhancing patient clinical safety benchmarks.
🦴 Osteoporosis Blends
Used as a professional active base for synthesizing annual post-menopausal bone density restoration lines. Consequently, it is vital for high-performance stabilization controls.
🔬 Mevalonate Assays
Acts as an essential reference standard block for modern enzyme inhibition pathways and drug trials. Specifically, it supports rapid compounding and formula clarity.
Technical Specifications
| Parameter | Standard Value |
|---|---|
| Product Name | Zoledronic Acid |
| Assay / Purity (HPLC) | 98.0% – 102.0% (On Anhydrous Basis) |
| Appearance | White crystalline powder |
| Water Content (Monohydrate) | 6.2% – 7.2% |
| Bacterial Endotoxins | Strictly compliant with parenteral infusion limits |
| CAS Number | 118072-93-8 (Anhydrous: 118072-92-7) |
📝 Safety & Handling: Formulated strictly for controlled pharmaceutical manufacturing, parenteral compounding, and clinical laboratory workflows. Zoledronic Acid is an exceptionally potent active drug block with strong bone-remodeling affinity that poses systemic reproductive toxicity, skeletal modification risks, and severe mucosal or eye irritation upon structural exposure. Therefore, store strictly in a cool, dry, dark location away from direct sunlight, ambient humidity fields, and incompatible alkali materials in its original safety-sealed airtight containers. Avoid any fine dust generation or open atmospheric dispersal loops during mass blending scales to secure industrial operators. Operating with localized down-flow containment booths, clinical-grade ventilation, and wearing full specialized protective equipment (PPE)—including double nitrile gloves, protective lab coats, face shields, and certified high-efficiency HEPA particulate respirators—is mandatory. Always consult the Safety Data Sheet (SDS) for detailed protocols.
